Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine Co-induction for Patients With Major Depressive Disorder; a Randomized Clinical Trial

NCT03666494 is registered in ClinicalTrials.gov with University of Saskatchewan as lead sponsor.

NCT NCT03666494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03666494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine Co-induction for Patients With Major Depressive Disorder; a Randomized Clinical Trial
Lead sponsor
University of Saskatchewan
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2018
Completion date
December 31, 2019
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, depression, ketamine